Matteo Giaj Levra
162 works · 4,872 citations · h-index 24
Top works
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
- Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
- A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics
- Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
- Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients☆
- 1276P Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): Real-world 3-year outcomes within overall and special populations (the UNIVOC study)
- Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis
- Clinical Implications and Added Costs of Incidental Findings in an Early Detection Study of Lung Cancer by Using Low-Dose Spiral Computed Tomography
- Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review
- Polymerase η mRNA Expression Predicts Survival of Non–Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
- P1.07-012 Efficacy of Immune Checkpoint Inhibitors in Large Cell Neuroendocrine Lung Cancer: Results from a French Retrospective Cohort
- Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients
- ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
- Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
- Extending Survival of Stage IV Non-Small Cell Lung Cancer
- Fetal Adenocarcinoma of the Lung in a 25-Year-Old Woman
- EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease
- Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
- Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study